Modulatory effect of the PDE-5 inhibitor sildenafil in diabetic neuropathy.
Patil, Chandrashekhar S
Modulatory effect of the PDE-5 inhibitor sildenafil in diabetic neuropathy. [electronic resource] - Pharmacology Nov 2004 - 190-5 p. digital
Publication Type: Journal Article
0031-7012
10.1159/000080104 doi
3',5'-Cyclic-GMP Phosphodiesterases--antagonists & inhibitors
Animals
Cyclic Nucleotide Phosphodiesterases, Type 5
Diabetes Mellitus, Experimental--complications
Diabetic Neuropathies--complications
Dose-Response Relationship, Drug
Female
Hyperalgesia--complications
Male
Methylene Blue--pharmacology
Mice
NG-Nitroarginine Methyl Ester--pharmacology
Pain Threshold--drug effects
Phosphodiesterase Inhibitors--therapeutic use
Piperazines--therapeutic use
Purines
Rats
Rats, Wistar
Sildenafil Citrate
Sulfones
Modulatory effect of the PDE-5 inhibitor sildenafil in diabetic neuropathy. [electronic resource] - Pharmacology Nov 2004 - 190-5 p. digital
Publication Type: Journal Article
0031-7012
10.1159/000080104 doi
3',5'-Cyclic-GMP Phosphodiesterases--antagonists & inhibitors
Animals
Cyclic Nucleotide Phosphodiesterases, Type 5
Diabetes Mellitus, Experimental--complications
Diabetic Neuropathies--complications
Dose-Response Relationship, Drug
Female
Hyperalgesia--complications
Male
Methylene Blue--pharmacology
Mice
NG-Nitroarginine Methyl Ester--pharmacology
Pain Threshold--drug effects
Phosphodiesterase Inhibitors--therapeutic use
Piperazines--therapeutic use
Purines
Rats
Rats, Wistar
Sildenafil Citrate
Sulfones